Retail sales slowed down in April
Americans are keeping a closer watch on their wallets.
U.S. economy
Divisions emerge among House Republicans over how much to cut taxes and Medicaid in Trump’s bill
Cheers broke out early Wednesday as Republicans on the House Ways and Means Committee signed off on the GOP tax breaks bill after a grueling round-the-clock session that pushed President Donald Trump’s package past overwhelming Democratic opposition.
Child care costs increased in 2024
Child care is getting more and more expensive with the annual price of child care increasing by 29% from 2020 to 2024.
Stocks are wavering on Wall Street and holding on to gains they made earlier in the week
Stocks are wavering on Wall Street and holding on to gains they made earlier in the week after the U.S. and China declared a temporary cease-fire in their trade war.
Credit card, auto loan debts fall
According to new data, Americans cleaned up some credit card and auto loan debt to start the year.
Tariffs raising prices on products
Tariffs have already made certain everyday products more expensive.
US egg prices fall for the first time in months but remain near record highs
U.S. retail egg prices fell in April from the record-high prices they hit earlier this year, according to government data released Tuesday.
FDA and RFK Jr. aim to remove ingestible fluoride products used to protect kids’ teeth
U.S. health regulators announced plans Tuesday to phase out ingestible fluoride supplements sometimes used to strengthen children’s teeth, opening a new front in Health Secretary Robert F. Kennedy Jr.’s effort against a mainstay of dental care.
Wall Street’s momentum fades following Monday’s spurt and US stocks are drifting in mixed trading
U.S. stocks are drifting in mixed trading on Tuesday following a report that showed inflation unexpectedly slowed across the country last month.
Trump signs executive order setting 30-day deadline for drugmakers to lower prescription drug costs
President Donald Trump on Monday signed a sweeping executive order setting a 30-day deadline for drugmakers to electively lower the cost of prescription drugs in the U.S. or face new limits down the road over what the government will pay.
